Delayed neurological events after mumps vaccination: implications for surveillance and clinical recognition

Masazumi Miyahara1, Kyoko Osaki2, Manami Negoro3

  • 1Pediatrics, Okanami General Hospital, Iga, Mie, Japan masazumi.m@k6.dion.ne.jp.

BMJ Case Reports
|February 15, 2026
PubMed

Insights

A rare case of febrile status epilepticus and aseptic meningitis occurred 23 days post-mumps vaccination. This highlights potential gaps in vaccine safety monitoring for delayed neurological events.

Area of Science:

  • Neurology
  • Vaccinology
  • Infectious Diseases

Background:

  • Febrile status epilepticus and aseptic meningitis are serious neurological conditions.
  • Mumps vaccination is a common preventative measure.
  • Delayed adverse events following vaccination can occur.

Purpose of the Study:

  • To report a case of delayed neurological complications after mumps vaccination.
  • To highlight the need for enhanced vaccine safety surveillance.
  • To emphasize clinician awareness of potential long-term vaccine effects.

Main Methods:

  • Case report of a previously healthy male infant.
  • Identification of the mumps vaccine strain (Hoshino) in cerebrospinal fluid.
  • Utilized reverse transcription-polymerase chain reaction (RT-PCR) and sequencing.

Main Results:

  • The patient developed febrile status epilepticus and aseptic meningitis 23 days post-vaccination.
  • The Hoshino mumps vaccine strain was confirmed in the cerebrospinal fluid.
  • The infant recovered fully without lasting neurological deficits.

Conclusions:

  • This case suggests potential limitations in current vaccine safety monitoring systems.
  • Longer surveillance periods and increased diagnostic vigilance are recommended.
  • Clinician awareness of delayed neurological complications post-vaccination is crucial.